Lupus-related protein-losing enteropathy associated with pseudo-pseudo Meigs’ syndrome and successfully treated with hydroxychloroquine

1. ARINGER M., COSTENBADER K., DAIKH D., BRINKS R., MOSCA M., RAMSEY-GOLDMAN R., et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–9.10.1136/annrheumdis-2018-21481931383717Search in Google Scholar

2. AL-MOGAIREN SM. Lupus protein-losing enteropathy (LUPLE): a systematic review. Rheumatol Int. 2011;31(8):995–1001.10.1007/s00296-011-1827-921344315Search in Google Scholar

3. TIALMA WA. Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome. Gynecol Oncol. 2005;97(1):288–91.10.1016/j.ygyno.2004.12.02215790480Search in Google Scholar

4. HOCHBERG MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.10.1002/art.17804009289324032Search in Google Scholar

5. PETRI M., ORBAI AM., ALARCON GS., GORDON C., MERRILL JT., FORTIN PR., et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.10.1002/art.34473340931122553077Search in Google Scholar

6. YOSHIDA M., MIYATA M., SAKA M., SASAJIMA T., SATO H., TAKIGUCHI J., et al. Protein-losing enteropathy exacerbated with the appearance of symptoms of systemic lupus erythematosus. Intern Med. 2001;40(5):449–53.10.2169/internalmedicine.40.44911393422Search in Google Scholar

7. CHUNG U., OKA M., NAKAGAWA Y., NISHISHITA T., SEKINE N., TANAKA Y., et al. A patient with protein-losing enteropathy associated with systemic lupus erythematosus. Intern Med. 1992;31(4):521–4.10.2169/internalmedicine.31.5211633362Search in Google Scholar

8. WERNER DE CASTRO GR., APPENZRLLER S., BERTOLO MB., COSTALLAT LT. Protein-losing enteropathy associated with systemic lupus erythematosus: response to cyclophosphamide. Rheumatol Int. 2005;25(2):135–8.10.1007/s00296-004-0483-815249982Search in Google Scholar

9. TANSIR G., KUMAR P., PIUS A., SUNNY SK., SONEJA M. Pseudo-pseudo Meigs’ syndrome: a rare presentation of systemic lupus erythematosus. Reumatismo. 2019;71(2):108–12.10.4081/reumatismo.2019.114031309785Search in Google Scholar

10. YANG Z., LIANG Y., LI C., ZHONG R. Serum CA125 elevation is independently associated with serositis in SLE patients. Clin Exp Rheumatol. 2012;30(1):93–8.Search in Google Scholar

11. ZEIMET AG., MARTH C., OFFNER FA., OBRIST P, UHL-STEIDL M., FEICHTINGER H. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Gynecol Oncol. 1996;62(3):384–9.10.1006/gyno.1996.02538812537Search in Google Scholar

12. LI T, XIE QB. A case report of pseudo-pseudo Meigs’ syndrome. Chin Med J (Engl). 2019;132(12):1497–8.10.1097/CM9.0000000000000231662932231205113Search in Google Scholar

13. FAVA A, PETRI M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1–13.10.1016/j.jaut.2018.11.001631063730448290Search in Google Scholar

14. Health and Labor Sciences Research Grant Subsidy for Intractable Disease Policy Research. Project, Research on autoimmune diseases, Japan college of Rheumatology. Guideline for the management of systemic lupus erythematosus 2019;2019:226-30 (in Japanese)Search in Google Scholar

15. FANOURIAKIS A., KOSTOPOULOU M., ALUNNO A., ARINGER M., BAJEMA I., BOLETIS JN. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–45.10.1136/annrheumdis-2019-21508930926722Search in Google Scholar

16. HANAOKA H., IIDA H., KIYOKAWA T., TAKAKUWA Y., KAWAHATA K. Hydroxychloroquine improves the disease activity and allows the reduction of the corticosteroid dose regardless of background treatment in Japanese patients with systemic lupus erythematosus. Intern Med. 2019;58(9):1257–62.10.2169/internalmedicine.1999-18654322930626831Search in Google Scholar

17. MIYAGAWA I., NAKANO K., NAKAYAMADA S., IWATA S., HANAMI K., FUKUYO S. Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus. Int J Rheum Dis. 2019;22(3):434–42.10.1111/1756-185X.1338730338639Search in Google Scholar